181 related articles for article (PubMed ID: 35406744)
1. The Sin3A/MAD1 Complex, through Its PAH2 Domain, Acts as a Second Repressor of Retinoic Acid Receptor Beta Expression in Breast Cancer Cells.
Dahiya NR; Leibovitch BA; Kadamb R; Bansal N; Waxman S
Cells; 2022 Mar; 11(7):. PubMed ID: 35406744
[TBL] [Abstract][Full Text] [Related]
2. Interference with Sin3 function induces epigenetic reprogramming and differentiation in breast cancer cells.
Farias EF; Petrie K; Leibovitch B; Murtagh J; Chornet MB; Schenk T; Zelent A; Waxman S
Proc Natl Acad Sci U S A; 2010 Jun; 107(26):11811-6. PubMed ID: 20547842
[TBL] [Abstract][Full Text] [Related]
3. A 13-amino acid amphipathic alpha-helix is required for the functional interaction between the transcriptional repressor Mad1 and mSin3A.
Eilers AL; Billin AN; Liu J; Ayer DE
J Biol Chem; 1999 Nov; 274(46):32750-6. PubMed ID: 10551834
[TBL] [Abstract][Full Text] [Related]
4. Functional analysis of the Mad1-mSin3A repressor-corepressor interaction reveals determinants of specificity, affinity, and transcriptional response.
Cowley SM; Kang RS; Frangioni JV; Yada JJ; DeGrand AM; Radhakrishnan I; Eisenman RN
Mol Cell Biol; 2004 Apr; 24(7):2698-709. PubMed ID: 15024060
[TBL] [Abstract][Full Text] [Related]
5. Maximum growth and survival of estrogen receptor-alpha positive breast cancer cells requires the Sin3A transcriptional repressor.
Ellison-Zelski SJ; Alarid ET
Mol Cancer; 2010 Sep; 9():263. PubMed ID: 20920219
[TBL] [Abstract][Full Text] [Related]
6. Mad proteins contain a dominant transcription repression domain.
Ayer DE; Laherty CD; Lawrence QA; Armstrong AP; Eisenman RN
Mol Cell Biol; 1996 Oct; 16(10):5772-81. PubMed ID: 8816491
[TBL] [Abstract][Full Text] [Related]
7. Structural Insight into the Binding of TGIF1 to SIN3A PAH2 Domain through a C-Terminal Amphipathic Helix.
He X; Nie Y; Zhou H; Hu R; Li Y; He T; Zhu J; Yang Y; Liu M
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884456
[TBL] [Abstract][Full Text] [Related]
8. Blocking the PAH2 domain of Sin3A inhibits tumorigenesis and confers retinoid sensitivity in triple negative breast cancer.
Bansal N; Bosch A; Leibovitch B; Pereira L; Cubedo E; Yu J; Pierzchalski K; Jones JW; Fishel M; Kane M; Zelent A; Waxman S; Farias E
Oncotarget; 2016 Jul; 7(28):43689-43702. PubMed ID: 27286261
[TBL] [Abstract][Full Text] [Related]
9. Unique anti-activator protein-1 activity of retinoic acid receptor beta.
Lin F; Xiao D; Kolluri SK; Zhang X
Cancer Res; 2000 Jun; 60(12):3271-80. PubMed ID: 10866321
[TBL] [Abstract][Full Text] [Related]
10. Orphan receptor COUP-TF is required for induction of retinoic acid receptor beta, growth inhibition, and apoptosis by retinoic acid in cancer cells.
Lin B; Chen GQ; Xiao D; Kolluri SK; Cao X; Su H; Zhang XK
Mol Cell Biol; 2000 Feb; 20(3):957-70. PubMed ID: 10629053
[TBL] [Abstract][Full Text] [Related]
11. HBP1 and Mad1 repressors bind the Sin3 corepressor PAH2 domain with opposite helical orientations.
Swanson KA; Knoepfler PS; Huang K; Kang RS; Cowley SM; Laherty CD; Eisenman RN; Radhakrishnan I
Nat Struct Mol Biol; 2004 Aug; 11(8):738-46. PubMed ID: 15235594
[TBL] [Abstract][Full Text] [Related]
12. Sin3A recruits Tet1 to the PAH1 domain via a highly conserved Sin3-Interaction Domain.
Chandru A; Bate N; Vuister GW; Cowley SM
Sci Rep; 2018 Oct; 8(1):14689. PubMed ID: 30279502
[TBL] [Abstract][Full Text] [Related]
13. Solution structure of the interacting domains of the Mad-Sin3 complex: implications for recruitment of a chromatin-modifying complex.
Brubaker K; Cowley SM; Huang K; Loo L; Yochum GS; Ayer DE; Eisenman RN; Radhakrishnan I
Cell; 2000 Nov; 103(4):655-65. PubMed ID: 11106735
[TBL] [Abstract][Full Text] [Related]
14. The ErbB3 binding protein Ebp1 interacts with Sin3A to repress E2F1 and AR-mediated transcription.
Zhang Y; Akinmade D; Hamburger AW
Nucleic Acids Res; 2005; 33(18):6024-33. PubMed ID: 16254079
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of trans-retinoic acid-resistant human breast cancer cell growth by retinoid X receptor-selective retinoids.
Wu Q; Dawson MI; Zheng Y; Hobbs PD; Agadir A; Jong L; Li Y; Liu R; Lin B; Zhang XK
Mol Cell Biol; 1997 Nov; 17(11):6598-608. PubMed ID: 9343423
[TBL] [Abstract][Full Text] [Related]
16. Differential binding of Sin3 interacting repressor domains to the PAH2 domain of Sin3A.
Pang YP; Kumar GA; Zhang JS; Urrutia R
FEBS Lett; 2003 Jul; 548(1-3):108-12. PubMed ID: 12885416
[TBL] [Abstract][Full Text] [Related]
17. Solution structure of the mSin3A PAH2-Pf1 SID1 complex: a Mad1/Mxd1-like interaction disrupted by MRG15 in the Rpd3S/Sin3S complex.
Kumar GS; Xie T; Zhang Y; Radhakrishnan I
J Mol Biol; 2011 May; 408(5):987-1000. PubMed ID: 21440557
[TBL] [Abstract][Full Text] [Related]
18. The Mad1-Sin3B interaction involves a novel helical fold.
Spronk CA; Tessari M; Kaan AM; Jansen JF; Vermeulen M; Stunnenberg HG; Vuister GW
Nat Struct Biol; 2000 Dec; 7(12):1100-4. PubMed ID: 11101889
[TBL] [Abstract][Full Text] [Related]
19. PSF is a novel corepressor that mediates its effect through Sin3A and the DNA binding domain of nuclear hormone receptors.
Mathur M; Tucker PW; Samuels HH
Mol Cell Biol; 2001 Apr; 21(7):2298-311. PubMed ID: 11259580
[TBL] [Abstract][Full Text] [Related]
20. The FOXN3-NEAT1-SIN3A repressor complex promotes progression of hormonally responsive breast cancer.
Li W; Zhang Z; Liu X; Cheng X; Zhang Y; Han X; Zhang Y; Liu S; Yang J; Xu B; He L; Sun L; Liang J; Shang Y
J Clin Invest; 2017 Sep; 127(9):3421-3440. PubMed ID: 28805661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
